Published in Clin Infect Dis on March 15, 2008
Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time. J Virol (2010) 1.23
Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae (2011) 1.19
Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am J Respir Crit Care Med (2010) 1.14
Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation. Semin Respir Crit Care Med (2013) 0.98
The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation. Transplantation (2009) 0.94
Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens. Antimicrob Agents Chemother (2013) 0.85
Viral infections in lung transplant recipients. Semin Respir Crit Care Med (2010) 0.83
Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation. J Heart Lung Transplant (2009) 0.82
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients. BMC Infect Dis (2013) 0.80
Late respiratory infection after lung transplantation. Tuberc Respir Dis (Seoul) (2013) 0.78
The lung microbiome after lung transplantation. Expert Rev Respir Med (2014) 0.77
Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients. Transplantation (2015) 0.76
Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview. Transplantation (2016) 0.75
Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient. Case Rep Transplant (2016) 0.75
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med (2003) 7.64
Clinical classification of pulmonary hypertension. J Am Coll Cardiol (2004) 5.87
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant (2002) 5.49
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28
EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia (2008) 5.22
Inhaled iloprost for severe pulmonary hypertension. N Engl J Med (2002) 3.90
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation (2013) 3.90
Long-term outcomes of bilateral lobar lung transplantation. Eur J Cardiothorac Surg (2012) 2.76
Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res (2009) 2.61
Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol (2012) 2.57
ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg (2007) 2.37
ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg (2006) 2.33
Catamenial pneumothorax revisited: clinical approach and systematic review of the literature. J Thorac Cardiovasc Surg (2004) 2.26
Thoracoscopic treatment of pulmonary sequestration. Eur J Cardiothorac Surg (2006) 2.09
Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. Transplantation (2006) 2.07
Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res (2008) 2.06
A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma: A Review of 12 Years' Experience. J Thorac Oncol (2015) 1.99
Moderate altitude but not additional endurance training increases markers of oxidative stress in exhaled breath condensate. Eur J Appl Physiol (2009) 1.99
Posttransplant sinus surgery in lung transplant recipients with cystic fibrosis: a single institutional experience. Eur Arch Otorhinolaryngol (2012) 1.97
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation (2011) 1.92
Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg (2014) 1.90
Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis (2004) 1.89
Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J (2012) 1.83
Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. Lancet Oncol (2009) 1.81
Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J Infect Dis (2007) 1.78
CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. Eur J Cardiothorac Surg (2011) 1.76
Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci U S A (2006) 1.71
Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis. Clin Infect Dis (2004) 1.68
Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension. Respiration (2007) 1.67
Telomerase gene mutations are associated with cirrhosis formation. Hepatology (2011) 1.67
The BODE index after lung volume reduction surgery correlates with survival. Chest (2006) 1.66
Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy. Eur J Cardiothorac Surg (2012) 1.65
Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol (2004) 1.57
Antiviral treatment of cytomegalovirus infection and resistant strains. Expert Opin Pharmacother (2009) 1.55
Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells. Am J Respir Crit Care Med (2013) 1.50
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol (2003) 1.50
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion (2010) 1.49
Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplant. Leuk Lymphoma (2010) 1.46
Tolerability, safety and efficacy of conventional amphotericin B administered by 24-hour infusion to lung transplant recipients. Swiss Med Wkly (2002) 1.41
Lung transplantation for cystic fibrosis: a single center experience of 100 consecutive cases. Eur J Cardiothorac Surg (2011) 1.40
Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med (2004) 1.40
Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment. Respiration (2017) 1.39
Immunosuppression and lung cancer of donor origin after bilateral lung transplantation. Lung Cancer (2011) 1.39
Surfactant improves graft function after gastric acid-induced lung damage in lung transplantation. Ann Thorac Surg (2012) 1.39
Extended measurements of exhaled nitric oxide in adult lung transplant recipients. Transplantation (2010) 1.39
Sildenafil extends survival and graft function in a large animal lung transplantation model. Eur J Cardiothorac Surg (2006) 1.39
High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay. J Clin Microbiol (2002) 1.34
Cytomegalovirus primary envelopment occurs at large infoldings of the inner nuclear membrane. J Virol (2006) 1.34
The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg (2013) 1.31
Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis (2006) 1.28
Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg (2006) 1.28
The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res (2009) 1.28
Adrenal angiomyolipoma in lymphangioleiomyomatosis. Eur Radiol (2006) 1.26
Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol (2005) 1.25
Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. Anesthesiology (2009) 1.22
Functional inactivation of NF2/merlin in human mesothelioma. Lung Cancer (2008) 1.22
Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. J Thorac Oncol (2014) 1.20
A mouse model of orthotopic, single-lung transplantation. J Thorac Cardiovasc Surg (2009) 1.18
A review of lung transplant donor acceptability criteria. J Heart Lung Transplant (2003) 1.16
Accelerated treatment of postpneumonectomy empyema: a binational long-term study. J Thorac Cardiovasc Surg (2008) 1.15
Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo. Antiviral Res (2008) 1.14
A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes. Antiviral Res (2009) 1.13
The MARS feasibility trial: conclusions not supported by data. Lancet Oncol (2011) 1.13
Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages. J Virol (2008) 1.12
Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland. BMC Pulm Med (2013) 1.12
Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer. J Virol (2004) 1.11
GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E. Antiviral Res (2002) 1.11
Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care (2010) 1.10
Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend (2005) 1.09
MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes. J Biol Chem (2011) 1.09
Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Ann Rheum Dis (2011) 1.08
Hantavirus outbreak, Germany, 2007. Emerg Infect Dis (2008) 1.07
Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration. J Virol (2011) 1.07
Diagnosis, treatment and long-term outcome of solitary fibrous tumours of the pleura. Eur J Cardiothorac Surg (2007) 1.06
Role of hedgehog signaling in malignant pleural mesothelioma. Clin Cancer Res (2012) 1.05
Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system. Antiviral Res (2002) 1.04
Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma. Eur J Cardiothorac Surg (2009) 1.04
Inflammatory cytokines in pulmonary hypertension. Respir Res (2014) 1.03
The postpneumonectomy syndrome: clinical presentation and treatment. Eur J Cardiothorac Surg (2008) 1.03
Inactivation and Environmental Stability of Zika Virus. Emerg Infect Dis (2016) 1.03
The tegument protein UL71 of human cytomegalovirus is involved in late envelopment and affects multivesicular bodies. J Virol (2011) 1.03
Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant (2009) 1.03